The Aptose Biosciences Inc (APS) Receives “Outperform” Rating from Royal Bank Of Canada

The Aptose Biosciences Inc (APS) Receives “Outperform” Rating from Royal Bank Of Canada

Aptose Biosciences Inc (TSE:APS)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank Of Canada in a report released on Friday, StockTargetPrices.com reports. They currently have a C$24.00 price target on the stock.

Aptose Biosciences (TSE:APS) traded down 5.31% on Friday, hitting $3.03. 15,890 shares of the stock traded hands. The company’s 50 day moving average price is $2.90 and its 200-day moving average price is $3.21. Aptose Biosciences has a 12-month low of $2.51 and a 12-month high of $8.33. The stock’s market capitalization is $39.06 million.

About Aptose Biosciences

Related posts

Leave a Comment